Funded Tech Companies

Solstice Biologics

Wondering who provided funding to Solstice Biologics? venBio and Aeris Capital AG joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
Solstice Biologics
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
1700 Owens St. 595
San Francisco, CA 94158
USA
Website
Email Address
Not Recorded

Company Background Information

Overview
Solstice Biologics is a private company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. The company is developing small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics.
Profile
Solstice Biologics LinkedIn Company Profile
Social Media
Solstice Biologics Company Twitter Account
Company News
Solstice Biologics News
Facebook
Solstice Biologics on Facebook
YouTube
Solstice Biologics on YouTube
Last Transaction
12/31/2015

Financing History

Date
Type
Amount
Venture Equity
$4,000,000
Venture Equity
$7,500,000
Venture Equity
$18,000,000


Management Team

Title
Name
Email & Social
Founder
Steven Dowdy
  Steven Dowdy LinkedIn Profile  Steven Dowdy Twitter Account  Steven Dowdy News  Steven Dowdy on Facebook


Company Investors

  • venBio (Corey Goodman)
  • Aeris Capital AG (George Rehm)

 

 

 

Browse more funded tech companies:

Solsten | Solstice Neurosciences

 

Share this article

 


About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary